Biotech · Private company
Mereo BioPharma
Track this companyFree. Adds Mereo BioPharma to your Dealase workspace and tells you when its record changes.
Clinical trials172 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- Active treatment with a high dose of BGS649Phase 2 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- Active treatment with a low dose of BGS649Phase 2 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- Alvelestat oral tablet - dose 1Phase 2 · Alpha 1-Antitrypsin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Alvelestat oral tablet - dose 2Phase 2 · Alpha 1-Antitrypsin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- BCT197Phase 2 · Pulmonary Disease, Chronic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
- BCT197 Part APhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- BCT197 Part BPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- BGS649Phase 2 · Pelvic Pain Associated With Refractory EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- BGS649Phase 2 · Hypogonadotropic HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- EtigilimabPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Investigational new drug company code: BGS649Phase 2 · Obese Hypogonadotropic HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials17
- Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis ImperfectaPHASE2 · TERMINATED · started Apr 28, 2022ClinicalTrials.gov NCT05312697 · fetched Nov 12, 2026
- Setrusumab vs Placebo for Osteogenesis ImperfectaPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Feb 21, 2022ClinicalTrials.gov NCT05125809 · fetched Nov 12, 2026
- EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 1, 2021ClinicalTrials.gov NCT05715216 · fetched Nov 12, 2026
- A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic TumorsPHASE1_PHASE2 · COMPLETED · started Mar 23, 2021ClinicalTrials.gov NCT04761198 · fetched Nov 12, 2026
- COVID-19 Study of Safety and Tolerability of AlvelestatPHASE1_PHASE2 · COMPLETED · started Jan 25, 2021ClinicalTrials.gov NCT04539795 · fetched Nov 12, 2026
- Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin DeficiencyPHASE2 · COMPLETED · started Apr 8, 2019ClinicalTrials.gov NCT03679598 · fetched Nov 12, 2026
- A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.PHASE2 · COMPLETED · started Oct 29, 2018ClinicalTrials.gov NCT03636347 · fetched Nov 12, 2026
- An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis ImperfectaPHASE2 · WITHDRAWN · started Oct 31, 2017ClinicalTrials.gov NCT03216486 · fetched Nov 12, 2026
- A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804PHASE2 · COMPLETED · started Sep 11, 2017ClinicalTrials.gov NCT03118570 · fetched Nov 12, 2026
- A 6 Month Safety Extension Study of MBGS205PHASE2 · COMPLETED · started Nov 15, 2016ClinicalTrials.gov NCT02908074 · fetched Nov 12, 2026
- Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary DiseasePHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02700919 · fetched Nov 12, 2026
- Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic HypogonadismPHASE2 · COMPLETED · started May 12, 2016ClinicalTrials.gov NCT02730169 · fetched Nov 12, 2026
- Safety & Efficacy of BCT197 in Patients Undergoing Cardiac SurgeryPHASE2 · TERMINATED · started Sep 1, 2011ClinicalTrials.gov NCT01336959 · fetched Nov 12, 2026
- Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral DensityPHASE2 · COMPLETED · started Jul 1, 2011ClinicalTrials.gov NCT01406548 · fetched Nov 12, 2026
- Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal MenPHASE2 · TERMINATED · started Aug 1, 2010ClinicalTrials.gov NCT01200862 · fetched Nov 12, 2026
- BGS649 Monotherapy in Moderate to Severe Endometriosis PatientsPHASE2 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT01190475 · fetched Nov 12, 2026
- A Safety & Efficacy Study of BGS649 in Women With Refractory EndometriosisPHASE2 · TERMINATED · started Apr 15, 2010ClinicalTrials.gov NCT01116440 · fetched Nov 12, 2026